Although the BCR-ABL fusion gene has been determined as a pathogenic gene of CML, it is only used for the diagnosis of CML and does not reflect the molecular mechanism and three stages of CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.